{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:11:03Z","timestamp":1789996263058,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ijantimicag.2007.05.021","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T07:24:06Z","timestamp":1185002646000},"page":"345-351","source":"Crossref","is-referenced-by-count":21,"title":["TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents"],"prefix":"10.1016","volume":"30","author":[{"given":"I.","family":"Morrissey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Colclough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Northwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.05.021_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijantimicag.2005.04.022","article-title":"Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999\u20132003)","volume":"26","author":"Schito","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2005.12.008","article-title":"Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999\u20132003)","volume":"5","author":"Johnson","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib3","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard. Document M7-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib4","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006."},{"issue":"Suppl. S1","key":"10.1016\/j.ijantimicag.2007.05.021_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dkf808","article-title":"Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/jac\/dkg465","article-title":"Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme","volume":"52","author":"Canton","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.diagmicrobio.2005.08.012","article-title":"Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001\u20132004)","volume":"54","author":"Deshpande","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. S1","key":"10.1016\/j.ijantimicag.2007.05.021_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/dkh311","article-title":"Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001\u20132002","volume":"54","author":"Brown","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijid.2004.07.008","article-title":"Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999\u20132000","volume":"9","author":"Hoban","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(03)00015-4","article-title":"Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000\u20132001): report from the SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Jones","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2006-1722","article-title":"The use of systemic fluoroquinolones","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijantimicag.2006.04.007","article-title":"Call for international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae","volume":"28","author":"Schurek","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dkf131","article-title":"Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones","volume":"50","author":"Croisier","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/430829","article-title":"A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance","volume":"41","author":"Fuller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.05.021_bib15","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/AAC.48.9.3630-3635.2004","article-title":"Designing fluoroquinolone breakpoints for Streptococcus pneumoniae by using genetics instead of pharmacokinetics\u2013pharmacodynamics","volume":"49","author":"Smith","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T18:20:15Z","timestamp":1546712415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0924857907002683"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.05.021","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}